These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 10095164)

  • 1. Effects of recombinant human growth hormone on height and skeletal maturation in growth hormone-deficient children with and without severe pretreatment bone age delay.
    Frindik JP; Kemp SF; Sy JP
    Horm Res; 1999; 51(1):15-9. PubMed ID: 10095164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
    Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final height in non-growth hormone deficient children treated with growth hormone. The Italian Multicentre Study Group.
    Bernasconi S; Street ME; Volta C; Mazzardo G
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):261-6; discussion 267. PubMed ID: 9373443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
    Högler W; Briody J; Moore B; Lu PW; Cowell CT
    Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: the National Cooperative Growth Study experience.
    August GP; Julius JR; Blethen SL
    Pediatrics; 1998 Aug; 102(2 Pt 3):512-6. PubMed ID: 9685455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The response to growth hormone treatment in prepubertal children with growth hormone deficiency in Japan: Comparing three consecutive years of treatment data of The Foundation for Growth Science in Japan between the 1990s and 2000s.
    Isojima T; Hasegawa T; Yokoya S; Tanaka T
    Endocr J; 2017 Sep; 64(9):851-858. PubMed ID: 28679975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibitors: a useful additional therapeutic option for slowing down advanced bone age in boys with growth hormone deficiency.
    Akın Kağızmanlı G; Özalp Kızılay D; Besci Ö; Yüksek Acinikli K; Özen S; Demir K; Gökşen Şimşek RD; Böber E; Darcan Ş; Abacı A
    J Endocrinol Invest; 2024 May; 47(5):1227-1235. PubMed ID: 38040920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial.
    Mericq MV; Eggers M; Avila A; Cutler GB; Cassorla F
    J Clin Endocrinol Metab; 2000 Feb; 85(2):569-73. PubMed ID: 10690857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of bone age maturation and growth velocity in isolated growth hormone (GH) deficient boys with and without gonadal suppression treatment and in GH deficient boys with associated gonadotropin deficiency.
    Satoh M; Tanaka T; Hibi I
    J Pediatr Endocrinol Metab; 1997; 10(6):615-22. PubMed ID: 9467132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult height in growth hormone (GH)-deficient children treated with biosynthetic GH. The Genentech Growth Study Group.
    Blethen SL; Baptista J; Kuntze J; Foley T; LaFranchi S; Johanson A
    J Clin Endocrinol Metab; 1997 Feb; 82(2):418-20. PubMed ID: 9024229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of long-term growth hormone therapy on bone age and pubertal maturation in boys with and without classic growth hormone deficiency.
    Zadik Z; Chalew S; Zung A; Landau H; Leiberman E; Koren R; Voet H; Hochberg Z; Kowarski AA
    J Pediatr; 1994 Aug; 125(2):189-95. PubMed ID: 8040760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
    Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
    Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
    Fjellestad-Paulsen A; Simon D; Czernichow P
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predicting the near-final height in growth hormone-treated children and adolescents with chronic kidney disease.
    Nissel R; Lindberg A; Mehls O; Haffner D;
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1359-65. PubMed ID: 18198222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F; Lindberg A; Wilton P
    Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
    Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
    J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.